Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
18
05
2021
accepted:
07
10
2021
entrez:
10
11
2021
pubmed:
11
11
2021
medline:
6
1
2022
Statut:
epublish
Résumé
Leishmaniasis is a neglected disease caused by different species of the protozoa Leishmania spp. Cutaneous lesions are the most common clinical manifestation. This disease is prevalent in tropical and subtropical areas, including the Mediterranean basin. In Spain, Leishmania (L.) infantum is the only endemic species, but imported cases are often diagnosed. Different classical parasitological methods can be performed for cutaneous leishmaniasis (CL) diagnosis; but currently molecular techniques serve as a relevant tool for the detection and characterization of Leishmania parasites. We aimed to evaluate clinical and epidemiological characteristics of CL diagnosed patients by real-time PCR in a tertiary hospital over a six-year period. Clinical, epidemiological and microbiological data were retrospectively collected and analyzed. In our study, CL was confirmed in 59 (31.4%) out of 188 patients by real-time PCR, showing an increase over recent years: 11 cases of CL between 2014 and 2016 and 48 between 2017 and 2019. Real-time PCR was performed on skin swabs and/or biopsies samples, with a positivity of 38.5% and 26.5%, respectively. Results were 100% concordant when biopsy and skin swab were performed simultaneously. L. (L.) infantum was the most frequent species detected (50%), followed by L. (L.) major (45%) and Viannia subgenus (5%), which were detected only in imported cases. L. (L.) major was almost entirely detected in travelers/migrants from Morocco. Multiple and atypical skin lesions were more common in imported cases than in autochthonous cases (44.4% vs. 21.8%). An increase in both autochthonous and imported CL cases has been observed in past years in our hospital. Molecular techniques assist in improving CL diagnosis and characterization of the Leishmania species, mainly in imported cases.
Sections du résumé
BACKGROUND
Leishmaniasis is a neglected disease caused by different species of the protozoa Leishmania spp. Cutaneous lesions are the most common clinical manifestation. This disease is prevalent in tropical and subtropical areas, including the Mediterranean basin. In Spain, Leishmania (L.) infantum is the only endemic species, but imported cases are often diagnosed. Different classical parasitological methods can be performed for cutaneous leishmaniasis (CL) diagnosis; but currently molecular techniques serve as a relevant tool for the detection and characterization of Leishmania parasites. We aimed to evaluate clinical and epidemiological characteristics of CL diagnosed patients by real-time PCR in a tertiary hospital over a six-year period.
METHODOLOGY/PRINCIPAL FINDINGS
Clinical, epidemiological and microbiological data were retrospectively collected and analyzed. In our study, CL was confirmed in 59 (31.4%) out of 188 patients by real-time PCR, showing an increase over recent years: 11 cases of CL between 2014 and 2016 and 48 between 2017 and 2019. Real-time PCR was performed on skin swabs and/or biopsies samples, with a positivity of 38.5% and 26.5%, respectively. Results were 100% concordant when biopsy and skin swab were performed simultaneously. L. (L.) infantum was the most frequent species detected (50%), followed by L. (L.) major (45%) and Viannia subgenus (5%), which were detected only in imported cases. L. (L.) major was almost entirely detected in travelers/migrants from Morocco. Multiple and atypical skin lesions were more common in imported cases than in autochthonous cases (44.4% vs. 21.8%).
CONCLUSIONS/SIGNIFICANCE
An increase in both autochthonous and imported CL cases has been observed in past years in our hospital. Molecular techniques assist in improving CL diagnosis and characterization of the Leishmania species, mainly in imported cases.
Identifiants
pubmed: 34758023
doi: 10.1371/journal.pntd.0009884
pii: PNTD-D-21-00719
pmc: PMC8580242
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009884Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Rev Esp Salud Publica. 2012 Dec;86(6):555-64
pubmed: 23325131
J Clin Microbiol. 2006 Apr;44(4):1435-9
pubmed: 16597873
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):117-124
pubmed: 28776770
IDCases. 2019 Jun 11;17:e00570
pubmed: 31275804
Int J Dermatol. 2017 Jul;56(7):750-753
pubmed: 28247922
Actas Dermosifiliogr (Engl Ed). 2021 May 11;:
pubmed: 34045157
J Travel Med. 2009 Nov-Dec;16(6):395-401
pubmed: 19930379
Euro Surveill. 2010 Mar 11;15(10):19505
pubmed: 20403308
Acta Trop. 2019 Nov;199:105120
pubmed: 31376368
J Clin Microbiol. 2004 Nov;42(11):5249-55
pubmed: 15528722
Euro Surveill. 2016 Dec 8;21(49):
pubmed: 27983510
Acta Trop. 2002 Mar;81(3):197-202
pubmed: 11835896
Parasitology. 2014 Dec;141(14):1891-7
pubmed: 25111885
Euro Surveill. 2013 Jul 25;18(30):20540
pubmed: 23929183
PLoS One. 2015 Jun 26;10(6):e0129418
pubmed: 26114938
BMC Infect Dis. 2019 Jul 15;19(1):623
pubmed: 31307404
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1999-2003
pubmed: 29704265
Euro Surveill. 2013 Jul 25;18(30):20545
pubmed: 23929179
Trop Med Int Health. 2020 Oct;25(10):1168-1181
pubmed: 32677284
Lancet Infect Dis. 2007 Sep;7(9):581-96
pubmed: 17714672
Parasit Vectors. 2018 May 2;11(1):273
pubmed: 29716641
Clin Dermatol. 2020 Mar - Apr;38(2):140-151
pubmed: 32513395
Parasit Vectors. 2020 Jan 13;13(1):24
pubmed: 31931865
PLoS One. 2012;7(5):e35671
pubmed: 22693548
Rev Inst Med Trop Sao Paulo. 2017 Jun 01;59:e38
pubmed: 28591266
Diagn Microbiol Infect Dis. 2003 Sep;47(1):349-58
pubmed: 12967749
Am J Trop Med Hyg. 2011 Nov;85(5):820-5
pubmed: 22049034
Actas Dermosifiliogr. 2015 May;106(4):310-6
pubmed: 25678133
PLoS Negl Trop Dis. 2015 Mar 10;9(3):e0003594
pubmed: 25756785
PLoS Negl Trop Dis. 2019 Apr 9;13(4):e0007321
pubmed: 30964864
J Clin Microbiol. 2006 Jul;44(7):2343-7
pubmed: 16825347
Microbes Infect. 2005 Aug-Sep;7(11-12):1224-34
pubmed: 16002315
PLoS Negl Trop Dis. 2019 Aug 30;13(8):e0007708
pubmed: 31469834
J Clin Microbiol. 2013 Jun;51(6):1826-33
pubmed: 23554201
Acta Trop. 2017 Sep;173:11-16
pubmed: 28527882
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
J Infect. 2011 Jul;63(1):76-82
pubmed: 21658772